Overview
InteraXon created the Muse headband, a consumer EEG device that provides real-time brain feedback during meditation and sleep to guide users toward calmer mental states. The Muse S and Muse 2 are among the best-selling consumer neurofeedback devices worldwide.
InteraXon is a Toronto-based neurotechnology company best known for developing the Muse headband, a consumer-grade electroencephalography (EEG) wearable designed to make brain monitoring accessible to everyday users. The device translates real-time brainwave activity into auditory feedback, guiding users toward calmer, more focused mental states during meditation and sleep sessions. Muse 2 and Muse S represent the company's flagship products, offering multi-sensor biometric tracking that extends beyond EEG to include heart rate, breath, and body movement data. This integrated approach positions InteraXon at the intersection of consumer wellness and clinical-grade neurofeedback technology.
InteraXon has established itself as one of the leading consumer neurofeedback brands globally, with the Muse S and Muse 2 ranking among the best-selling EEG wearables on the market. The company has raised over $37 million in funding through a Series C round, reflecting sustained investor confidence in its technology and business model. Muse devices have been adopted not only by individual consumers but also by researchers and clinicians, with the hardware and accompanying data platform supporting hundreds of peer-reviewed studies on meditation, stress, and sleep. This dual foothold in consumer retail and academic research has helped InteraXon build both brand credibility and a growing body of clinical validation.
InteraXon holds meaningful significance for the broader neurotechnology industry by demonstrating that EEG-based neurofeedback can be made approachable, affordable, and commercially viable at scale. At a time when many neurotech applications remain confined to clinical or laboratory settings, Muse has helped normalize brain-computer interface concepts among mainstream audiences. The company's success has effectively lowered the barrier to entry for neurofeedback adoption, creating a template that other consumer neurotech developers continue to reference. By bridging the gap between scientific rigor and consumer usability, InteraXon has played a foundational role in shaping how the industry thinks about accessible brain health technology.
More in Neurofeedback
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Neurofeedback
Location
Toronto, Canada
Funding
Series C ยท $37M+
Website
choosemuse.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ